OSAM
COGT icon

O'Shaughnessy Asset Management’s Cogent Biosciences COGT Stock Holding History

O'Shaughnessy Asset Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,283
Closed -$294K – 2694
2025
Q4 		$294K Buy
+8,283
New +$233K ﹤0.01% 1782

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

O'Shaughnessy Asset Management's COGT Position: Q1 2026 in Review

O'Shaughnessy Asset Management sold out of Cogent Biosciences (COGT) in Q1 2026, closing a stake of 8,283 shares — an estimated $294K sold.

O'Shaughnessy Asset Management first reported a position in COGT in Q4 2025 and held it in 1 quarter. The position peaked at $294K in Q4 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • O'Shaughnessy Asset Management reported no remaining Cogent Biosciences position as of Q1 2026 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 8,283 Cogent Biosciences shares in Q1 2026, an estimated $294K.
  • O'Shaughnessy Asset Management first reported a position in Cogent Biosciences in Q4 2025 and held it in 1 quarter.
  • O'Shaughnessy Asset Management's Cogent Biosciences position peaked at $294K in Q4 2025.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2026, filed 13 May 2026.